1992
DOI: 10.1097/00000421-199202000-00009
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Amonafide in Cervical Cancer, Phase II

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
28
0

Year Published

1994
1994
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 57 publications
(29 citation statements)
references
References 0 publications
1
28
0
Order By: Relevance
“…During our search for anticancer drugs appended to excellent polyamine carriers according to the established structure-activity relationships, we found 1,8-naphthalimide architectures, which have been evaluated extensively as antitumor agents, were attractive for their marked structural similarity to anthracene, the model cargo in prior work [5,7]. Preliminary results confirmed that the naphthalimide conjugated with both native spermidine (Spd) and synthetic homospermidine have enhanced cytotoxicity to cancer cells (e.g., Bel-7402 cells) over their normal cell counterparts (QSG7701 cells) in vitro, and induced B16 cell apoptosis [8].…”
Section: Introductionmentioning
confidence: 99%
“…During our search for anticancer drugs appended to excellent polyamine carriers according to the established structure-activity relationships, we found 1,8-naphthalimide architectures, which have been evaluated extensively as antitumor agents, were attractive for their marked structural similarity to anthracene, the model cargo in prior work [5,7]. Preliminary results confirmed that the naphthalimide conjugated with both native spermidine (Spd) and synthetic homospermidine have enhanced cytotoxicity to cancer cells (e.g., Bel-7402 cells) over their normal cell counterparts (QSG7701 cells) in vitro, and induced B16 cell apoptosis [8].…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, numerous naphthalimide derivatives have been synthesized and evaluated as antitumor agents (6–8). The continuing success of naphthalimide‐based anticancer drugs (9) and recent introduction of its several derivatives into clinical trials [Amonafide 1 (10), Azonafide 2 (11), and DMP‐840 3 (12), Figure 1] demonstrated that naphthalimide derivatives represented a group of promising anticancer drugs.…”
mentioning
confidence: 99%
“…Naphthalimides, which are characterized by the presence of a coplanar chromophore and, usually, a p-deficient aromatic system, as well as one or two basic side chains, constitute an important class of prodrugs in anticancer therapy (Kamal et al, 2002;Braña et al, 2003;Malviya et al, 1992). They display high levels of antitumor activity toward multifarious murine and human tumor cells (Malviya et al, 1992;Braña and Ramos, 2001).…”
Section: Introductionmentioning
confidence: 99%
“…They display high levels of antitumor activity toward multifarious murine and human tumor cells (Malviya et al, 1992;Braña and Ramos, 2001). Two members of this class of compounds, amonifide and mitonafide, are undergoing clinical trials (Malviya et al, 1992).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation